
Vision
To create a transformative life science ecosystem in central London dedicated to innovation, creative partnerships and to improve life for our local and global communities.
About Us
SC1 is a life science district in south central London. It aims to transform healthcare, accelerate innovation, and tackle big problems in order to make a healthier future a reality for all of us.
Founded by King’s Health Partners, Guy’s & St Thomas’ Foundation, and Lambeth and Southwark councils, SC1 is born from the unique diversity of London. It is part of a thriving community at the heart of the city, bringing together local services with leading institutions and innovative businesses in a world renowned location.
Within SC1 there are ambitious plans underway that will create significant new spaces for health and life sciences, increase employment opportunities, support new innovative business, develop cultural programmes, and build a world recognised home for life sciences innovation.

Our Core Initiatives

Our Founders

King’s Health Partners
King's Health Partners is a world leading Academic Health Sciences Centre based in south east London. Its tripartite mission is to pioneer better healthcare for all by integrating world class research, care, education and training. Its work translates research more rapidly into clinical practice for the benefit of patients, then effectively disseminating those advances through education and training.
It brings together three leading NHS Foundation Trusts – Guy's and St Thomas’ now incorporating Royal Brompton and Harefield, King’s College Hospital and South London and Maudsley – with a globally renowned university, King’s College London.
London Borough of Lambeth and London Borough of Southwark
Working with the other co-founders, both Lambeth and Southwark have been instrumental in helping to establish SC1. Each local authority will continue to support the development of SC1 alongside their respective public health teams. There is high level engagement from each borough, with CEO and Cabinet Member involvement on the Board, and senior management involvement in the day-to-day progression of SC1. The ongoing involvement of Lambeth and Southwark will be crucial to securing inward investment, economic development and community engagement. Cooperation with the the Mayor of London’s Office, other local institutions and their local business communities also facilitated by the boroughs.
Guy’s & St Thomas’ Foundation
Guy’s & St Thomas’ Foundation’s mission is to build the foundations of a healthier society. Their commitment and work are backed by an endowment, which allows them to take a long-term view while addressing the real and urgent health issues of today. At close to £1 billion, their endowment is one of the largest in the UK, made up of a diversified portfolio of investments including land and other residential, student and commercial properties, in and around their location in the South London boroughs of Lambeth and Southwark. They invest, partner, engage and influence to come at big health challenges from all angles. They are a family of forward-looking organisations, including Impact on Urban Health and the charities supporting Guy's and St Thomas' NHS Foundation Trust. The Foundation collaborates with communities, partners and hospitals, and use their assets to transform lives. Because a healthier society is their collective endeavour.

Our Leadership
-
SC1 Co-ChairLord Kakkar joins King’s Health Partners with a wealth of high profile experience in healthcare, having previously served as Professor of Surgery at University College London and Chairman of UCLPartners Academic Health Science Partnership, and is Director of the Thrombosis Research Institute London. He brings with him significant understanding of policy making, national healthcare challenges and the political landscape; he is a Life Peer and sits on the crossbenches of the House of Lords. He is also a member of the Privy Council and is Chairman of the Judicial Appointments Commission, and served as Chairman of the House of Lords Appointments Commission from 2013–2018.
As Independent Chair, Lord Kakkar is responsible for overseeing and optimising the governance of King’s Health Partners Board to create an agile system of partnership development and delivery so that innovation may flourish. He will shape, influence and articulate the purpose and goals of King’s Health Partners at a regional, national and international level, developing an ambitious strategy to harness the system’s innovation and drive best-in-class partnership working and integrated research capability for the benefit of our patients and population.
-
SC1 Co-ChairAfter stepping down from his roles as Senior Vice-President (Health) at King’s College London and Executive Director of King’s Health Partners Academic Health Sciences Centre, Sir Robert Lechler has taken up the role of Co-Chair for SC1. He now holds a range of roles including Board membership for two biotech start up companies, chairing an external advisory Board for Birmingham Health Partners, and chairing the London Mozart Players Trust.
In 2012 Robert was awarded a Knighthood in the Queen’s Birthday honours for Services to Academic Medicine and in 2015 was elected as the President of the UK Academy of Medical Sciences. In addition, Robert was a Founding Board Member of MedCity, was a Board Member of the Crick Institute, and spent five years as a member of the Prime Minister’s Council for Science and Technology.

-
Executive Director
SC1
Georgina Rizik is a global healthcare executive with over 25 years of experience across the private, public and non-profit sectors. Georgina brings international commercialisation expertise in oncology and specialty medicine, with a career in Biotechnology (Novartis, Roche, Boehringer Ingelheim, Ipsen) that spans leadership roles in global product/portfolio strategy, lifecycle management, business development, launch planning & operations, and country roles in marketing, sales, new product planning and medical affairs. Georgina had the privilege to contribute to the local and global success for the following transformative Oncology medications: Femara®, Gleevec®, Zometa®, Xeloda®, Herceptin® and Avastin®. An advocate for global health equity, Georgina is also a pioneer in the development of innovative Go To Market strategies for Oncology Biosimilars.
Most recently, Georgina has been quite engaged in the start-up ecosystem in Canada as an Advisor to Health Tech and Biotech companies. She is an Associate (Mentor) at the Creative Destruction Lab (global accelerator) and a Strategic Advisor at VoxCell BioInnovation.
Georgina is a globally minded business leader with strategic and cultural agility having worked in Canada, Switzerland, Germany and the UK with deep knowledge of the Canadian, European, US and international healthcare ecosystems. Experienced in leading teams, these diverse roles have fostered Georgina’s entrepreneurial and collaborative skills, generating global best practices.
An accomplished biopharmaceutical leader, Georgina has been recognized by PM360, as one of the 2017 PM360 ELITE 100 in the Strategist category. The PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the 100 most influential people in the healthcare industry.
Georgina spent the first five years of her professional journey as a Clinical Pharmacist in Canada and has a Bachelor of Science in Pharmacy (BScPhm) degree from the University of Toronto. In 2009, she earned her executive MBA from the Kellogg-Schulich EMBA Program (Chicago, USA & Toronto, Canada).
Georgina is a purpose-driven leader who is passionate about transforming the global approach to the commercialisation of innovation in order to drive personalised care and health equity.
-
Senior Vice President (Health & Life Sciences)
King’s College London
Executive Director
King’s Health Partners
Richard has held the positions of Senior Vice President (Health & Life Sciences), King’s College London and Executive Director of King’s Health Partners since September 2020. Richard trained in Medicine and Clinical Genetics in London prior to moving to the University of Leicester in 1992 where he was later appointed to the Foundation Chair of Medical Genetics. He returned to King’s as Professor of Medical Genetics in 2005, being appointed as founding Director of the KCL/GSTT NIHR Comprehensive Biomedical Research Centre.
Richard has substantial academic leadership experience. Prior to his present appointment, he was Vice-Principal for Health at Queen Mary University London and Executive Dean of Barts and The London School of Medicine and Dentistry. Richard is a Fellow of the Academy of Medical Sciences and King’s College London, and Emeritus NIHR Senior Investigator.
Richard’s research has focused on identification of human disease genes, enabled by emerging genomics technologies. Most recently he co-founded the Genes and Health project (www.genesandhealth.org). This programme is one of the world’s largest community-based genetics studies, aiming to improve health among people of Pakistani and Bangladeshi heritage living in England. The programme is now supported through a multi-pharma industry consortium.
-
Chief Executive
Guy’s and St Thomas’ NHS Foundation Trust
Ian became the Chief Executive Officer of Guy's and St Thomas' NHS Foundation Trust in July 2019. Prior to this, he was appointed Medical Director in January 2011 and Chief Medical Officer in January 2017. Ian was educated at Colfe’s School London, at St Thomas’s Hospital Medical School and at Pembroke College Cambridge. He holds the degrees of BSc in Immunology and MB BS in Medicine, is a Fellow of the Royal College of Physicians of London and holds an MBA from the University of Cambridge. Ian has had a career in renal medicine at Guy’s Hospital, both as a postgraduate and as a consultant. His main clinical interest is renal transplantation. His research was focused on the biology of renal transplant rejection in which he undertook research in Oxford and in London and his clinical career was as a transplant nephrologist. He also has an interest in immune renal disease including systemic lupus. Over the last 10 years he has held a number of posts in medical leadership and management at Guy’s and St Thomas’. In recognition of his commitment to research and education, he holds a Senior Lecturer position in the Faculty of Medicine, Kings College London. Ian also holds a number of national roles in medicine and in the life sciences. He is Chair of the National Institutes of Health Research Clinical Research Network, the organisation accountable for national clinical research strategy and delivery in England and is the former Chair of the Association of UK University Hospitals Medical Directors Board, the group of university organisations accountable for the majority of UK medical research and education. He is Chair of the London Genomics Medicine consortium and of Digital Health.London, the consortium of London academic organisations accountable for the development and delivery of digital health and technology. Ian became the President of the European Union Healthcare Alliance from December 2019 to May 2020. Most recently Ian has become a Professor of Practice at King’s College London. Outside medicine, Ian’s interests are those of his family (he is married with three daughters). His personal interests are to travel to as many rarely discovered parts of the world is possible, sailing and skiing, rugby and cricket and literature.
-
Cabinet Member for Health and WellbeingSouthwark Council
Councillor Evelyn Akoto leads the council’s public health work and its partnership with the NHS, including the public health response to COVID-19. She has worked to reduce health inequality in the borough including tackling HIV, drug and alcohol services and mental health issues. In addition, Cllr Akoto has worked on safeguarding the needs of vulnerable adults, the provision of personal social services, services to older people and services to people with disabilities.
-
Chief Executive
Guy’s & St Thomas’ Foundation
Kieron Boyle is the Chief Executive of the family of organisations part the south London-based philanthropic institution Guy’s & St Thomas’ Foundation. These include Impact on Urban Health, which works to unlock the potential of cities to be healthier, and the charities that support extraordinary patient and staff care at Guy’s and St Thomas’ NHS Foundation Trust. Kieron also stewards the management and investment of the Foundation’s endowment portfolio, which includes a substantive proportion of land and property. Close to £1 billion, the endowment has a dual mandate of achieving both a financial return and health impact.
Since beginning his career at the Boston Consulting Group, Kieron has worked across the public sector at No.10, the Department for Business and the Foreign and Commonwealth Office. Kieron previously led the UK government’s work on impact investment, a role in which he helped form the G8 taskforce on social impact investment, and led initiatives creating the Access Foundation, Government Outcomes Lab and Dementia Discovery Fund.
Kieron sits on the Boards of Big Society Capital, the Design Council and Catch22. He chairs LIPH — a global coalition of institutional investors working to improve people’s health — as well as Nesta’s Cultural Impact Development Fund. He a is member of the Mayor of London’s Childhood Obesity Taskforce and on the advisory council of the Impact Investing Institute. In 2014 Kieron was selected as a Young Global Leader by the World Economic Forum.
-
Chief ExecutiveSouth London and Maudsley NHS Foundation Trust
David joined South London and Maudsley NHS Foundation Trust as Chief Executive in July 2019. He has extensive NHS operational experience in mental health, acute and community services. David began his career in the NHS in 1980 and has over 20 years’ experience at board level across different NHS trusts in London, Oxford and Surrey including nine years as a Chief Executive Officer. He is a board member of King's Health Partners, a Trustee on Maudsley Charity (the largest mental health charity in the UK) and on the advisory board of Mindful Healthcare. David is Chair of the Cavendish Square Group, which provides a collective voice for the providers of NHS mental health services in London, and for the broader mental health community including clinicians and patients.
Before joining the Trust, David was Chief Executive at South West London and St George's NHS Trust. Through several award-winning change programmes, he transformed the organisation, improving the quality of services and care provided to patients. He led one of London’s most significant successful mental health development schemes with a new £180m state of the art hospital and overall £1bn redevelopment of the existing site.
David is one of the founders of the South London Mental Health and Community Partnership, a unique partnership of three London NHS trusts that, after being established in 2017, has transformed outcomes for people with specialist, often complex mental health problems. This was one of the first effective provider collaboratives to be set up in the NHS and redesigned services that have resulted in over £9m of savings reinvested in new services. The model regarded is widely regarded as a national blueprint for partnership working at a system level.
David completed his MBA at Henley Business School in 2001 and was selected to be on the NHS Top Leaders programme in 2011. He is passionate about tackling deep-rooted health inequalities and providing the best care for the people who use mental health services.
-
Leader
Lambeth Council
Councillor Claire Holland has been the Leader of Lambeth Council since 2021, and a councillor for Oval ward since 2014. She leads a large majority group in Lambeth, with Labour holding 58 out of the 63 seats.
As Leader of the Council, Claire is responsible for setting the overall political and strategic direction for Lambeth.
She is responsible for driving forward the council’s response to the climate and ecological crisis and working with SC1 partners to improve health equity in the borough by ensuring that the council's work is centred on increasing the economic resilience and wellbeing of Lambeth’s residents as part of a just transition to a healthier and net-zero future for the borough.
-
Chief Executive
King’s College Hospital NHS Foundation Trust
Professor Clive Kay joined King’s as Chief Executive in April 2019. Clive has extensive clinical and leadership experience, and prior to taking up his position at King’s he was Chief Executive at Bradford Teaching Hospitals NHS Foundation Trust from January 2015.
Previously he was Clinical Director of Radiology (2001-2006) and subsequently the Medical Director (2006-2014) at Bradford. Prior to working at Bradford, Clive was a Visiting Associate Professor of Radiology at the Medical University of South Carolina. He was a Member of Council of the Royal College of Radiologists, and former Chairman of both the Royal College of Radiologist’s Scientific Programme Committee and the British Society of Gastrointestinal and Abdominal Radiology.
He is currently a Fellow of the Royal College of Radiologists and a Fellow of the Royal College of Physicians of Edinburgh.

Collaborate
We're always looking for creative partnership opportunities that are aligned with our vision to transform the healthcare ecosystem, locally and globally. Please contact the Executive Director of SC1, Georgina Rizik, to initiate the conversation and potential proposal process.